documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
22 rows where docket_id = "FDA-1995-S-0036" and posted_year = 2021 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-S-0036-0203 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Table of Contents | Other | Background Material | 2021-12-13T05:00:00Z | 2021 | 12 | 2022-01-02T05:00:00Z | 2022-01-02T05:58:23Z | 0 | 0 | 0900006484ec1d33 | ||
| FDA-1995-S-0036-0205 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | UPMC Children’s Hospital of Pittsburgh Community Consultation & Public Disclosure Plan | Other | Background Material | 2021-12-13T05:00:00Z | 2021 | 12 | 2022-01-02T05:00:00Z | 2022-01-02T06:12:55Z | 0 | 0 | 0900006484ec1d37 | ||
| FDA-1995-S-0036-0204 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Submission Cover Letter | Other | Background Material | 2021-12-13T05:00:00Z | 2021 | 12 | 2022-01-02T05:00:00Z | 2022-01-02T06:12:00Z | 0 | 0 | 0900006484ec1d35 | ||
| FDA-1995-S-0036-0197 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Table of Contents | Other | Background Material | 2021-10-26T04:00:00Z | 2021 | 10 | 2021-10-26T04:00:00Z | 2021-10-26T17:28:19Z | 0 | 0 | 0900006484df8a3b | ||
| FDA-1995-S-0036-0200 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Community Consultation & Public Disclosure Plan from Baylor College of Medicine | Other | Letter(s) | 2021-10-26T04:00:00Z | 2021 | 10 | 2021-10-26T04:00:00Z | 2021-10-26T17:45:24Z | 0 | 0 | 0900006484df8a41 | ||
| FDA-1995-S-0036-0202 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Community Consultation & Public Disclosure Plan FROM Children’s Hospital Los Angeles | Other | Letter(s) | 2021-10-26T04:00:00Z | 2021 | 10 | 2021-10-26T04:00:00Z | 2021-10-26T17:50:57Z | 0 | 0 | 0900006484df8a45 | ||
| FDA-1995-S-0036-0198 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Cover Letter | Other | Letter(s) | 2021-10-26T04:00:00Z | 2021 | 10 | 2021-10-26T04:00:00Z | 2021-10-26T17:29:28Z | 0 | 0 | 0900006484df8a3d | ||
| FDA-1995-S-0036-0199 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Community Consultation & Public Disclosure Plan from Children’s Wisconsin | Other | Letter(s) | 2021-10-26T04:00:00Z | 2021 | 10 | 2021-10-26T04:00:00Z | 2021-10-26T17:41:45Z | 0 | 0 | 0900006484df8a3f | ||
| FDA-1995-S-0036-0201 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Community Consultation & Public Disclosure Plan from Children’s Medical Center, Dallas/University of Texas, Southwestern | Other | Letter(s) | 2021-10-26T04:00:00Z | 2021 | 10 | 2021-10-26T04:00:00Z | 2021-10-26T17:48:13Z | 0 | 0 | 0900006484df8a43 | ||
| FDA-1995-S-0036-0194 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure from The Children’s Hospital of Philadelphia | Other | Public Disclosure | 2021-09-24T04:00:00Z | 2021 | 9 | 2021-09-24T04:00:00Z | 2021-10-01T05:12:29Z | 0 | 0 | 0900006484d99c13 | ||
| FDA-1995-S-0036-0192 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure from The Children’s Hospital of Philadelphia | Other | Public Disclosure | 2021-09-24T04:00:00Z | 2021 | 9 | 2021-09-24T04:00:00Z | 2021-10-01T05:10:18Z | 0 | 0 | 0900006484d8e908 | ||
| FDA-1995-S-0036-0191 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure Report from Beth Israel Deaconess Medical Center | Other | Public Disclosure | 2021-09-24T04:00:00Z | 2021 | 9 | 2021-10-01T04:00:00Z | 2021-10-01T05:05:53Z | 0 | 0 | 090000648309ad33 | ||
| FDA-1995-S-0036-0196 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure Report from Kelly Hoy, Diffusion Pharmaceuticals Inc. - duplication of FDA-1995-S-0036-0190 | Other | Public Disclosure | 2021-09-24T04:00:00Z | 2021 | 9 | 2021-09-24T04:00:00Z | 2021-10-01T05:14:11Z | 0 | 0 | 090000648435aaeb | ||
| FDA-1995-S-0036-0195 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure from The Children’s Hospital of Philadelphia | Other | Public Disclosure | 2021-09-24T04:00:00Z | 2021 | 9 | 2021-10-01T04:00:00Z | 2021-10-01T05:13:02Z | 0 | 0 | 0900006484d99c60 | ||
| FDA-1995-S-0036-0193 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure from The Children’s Hospital of Philadelphia | Other | Public Disclosure | 2021-09-24T04:00:00Z | 2021 | 9 | 2021-09-24T04:00:00Z | 2021-10-01T05:11:56Z | 0 | 0 | 0900006484d99bc0 | ||
| FDA-1995-S-0036-0190 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Re: Prehospital Airway Control Trial (PACT) | Supporting & Related Material | Background Material | 2021-09-08T04:00:00Z | 2021 | 9 | 2021-09-08T16:04:59Z | 0 | 0 | 0900006484d60e22 | |||
| FDA-1995-S-0036-0189 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | University of Michigan Dept of Emergency Medicine End of study and Post-Trial Public Disclosure Report for IDE G160263 | Other | Supplement (SUP) | 2021-06-17T04:00:00Z | 2021 | 6 | 2021-06-17T04:00:00Z | 2021-06-17T12:58:51Z | 0 | 0 | 0900006484b904ec | ||
| FDA-1995-S-0036-0188 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure from Scott L. Weiss, MD MSCE | Other | Public Disclosure | 2021-05-25T04:00:00Z | 2021 | 5 | 2021-05-25T04:00:00Z | 2021-05-25T15:35:46Z | 0 | 0 | 0900006482ce9ef1 | ||
| FDA-1995-S-0036-0181 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | ESETT, Neurological Emergencies Treatment Trials (NETT) Network Report of Pre-trial Public Disclosure IND #119,756 | Other | Public Disclosure | 2021-02-05T05:00:00Z | 2021 | 2 | 2021-02-05T05:00:00Z | 2021-02-05T14:57:36Z | 0 | 0 | 0900006482b19fd4 | ||
| FDA-1995-S-0036-0180 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | ESETT, Neurological Emergencies Treatment Trials (NETT) & PECARN Networks Summary Report of Community Consultations for Public Disclosure IND #119,756 | Other | Public Disclosure | 2021-02-05T05:00:00Z | 2021 | 2 | 2021-02-05T05:00:00Z | 2021-02-05T14:57:28Z | 0 | 0 | 0900006482b19b84 | ||
| FDA-1995-S-0036-0182 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | ESETT, Neurological Emergencies Treatment Trials (NETT) & PECARN Networks Examples of Public Disclosure Materials IND #119,756 | Other | Public Disclosure | 2021-02-05T05:00:00Z | 2021 | 2 | 2021-02-05T05:00:00Z | 2021-02-05T14:57:41Z | 0 | 0 | 0900006482b19fd6 | ||
| FDA-1995-S-0036-0183 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Public Disclosure from Jason L Sperry, MD, MPH | Other | Public Disclosure | 2021-02-05T05:00:00Z | 2021 | 2 | 2021-02-05T05:00:00Z | 2021-02-05T14:57:45Z | 0 | 0 | 0900006482b6c6a1 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);